OCRX
Vanguard Group’s Ocera Therapeutics, Inc. OCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-713,169
| Closed | -$813K | – | 4103 |
|
|
2017
Q3 | $813K | Sell |
713,169
-37,773
| -5% | -$43.1K | ﹤0.01% | 3641 |
|
|
2017
Q2 | $871K | Sell |
750,942
-328,808
| -30% | -$381K | ﹤0.01% | 3600 |
|
|
2017
Q1 | $1.42M | Buy |
1,079,750
+905,957
| +521% | +$1.19M | ﹤0.01% | 3485 |
|
|
2016
Q4 | $365K | Sell |
173,793
-256,831
| -60% | -$539K | ﹤0.01% | 3791 |
|
|
2016
Q3 | $1.14M | Buy |
430,624
+21,789
| +5% | +$57.7K | ﹤0.01% | 3542 |
|
|
2016
Q2 | $777K | Buy |
408,835
+4,900
| +1% | +$9.31K | ﹤0.01% | 3676 |
|
|
2016
Q1 | $1.19M | Buy |
403,935
+22,710
| +6% | +$66.8K | ﹤0.01% | 3549 |
|
|
2015
Q4 | $1.19M | Buy |
381,225
+12,903
| +4% | +$40.2K | ﹤0.01% | 3568 |
|
|
2015
Q3 | $1.16M | Buy |
368,322
+11,069
| +3% | +$35K | ﹤0.01% | 3585 |
|
|
2015
Q2 | $1.36M | Buy |
357,253
+12,960
| +4% | +$49.2K | ﹤0.01% | 3568 |
|
|
2015
Q1 | $1.62M | Buy |
344,293
+54,809
| +19% | +$258K | ﹤0.01% | 3476 |
|
|
2014
Q4 | $1.84M | Sell |
289,484
-3,352
| -1% | -$21.4K | ﹤0.01% | 3316 |
|
|
2014
Q3 | $1.44M | Buy |
292,836
+85,525
| +41% | +$419K | ﹤0.01% | 3396 |
|
|
2014
Q2 | $1.58M | Buy |
207,311
+400
| +0.2% | +$3.06K | ﹤0.01% | 3352 |
|
|
2014
Q1 | $2.18M | Buy |
206,911
+49,818
| +32% | +$526K | ﹤0.01% | 3183 |
|
|
2013
Q4 | $2.04M | Buy |
157,093
+44,818
| +40% | +$582K | ﹤0.01% | 3175 |
|
|
2013
Q3 | $951K | Buy |
112,275
+12,275
| +12% | +$104K | ﹤0.01% | 3382 |
|
|
2013
Q2 | $47K | Buy |
+100,000
| New | +$47K | ﹤0.01% | 3767 |
|